DKd: daratumumab, carfilzomib, and dexamethasone; DPd: daratumumab, pomalidomide, and dexamethasone; DRd: daratumumab, lenalidomide, and dexamethasone; DVd: daratumumab, bortezomib, and dexamethasone; ERd: elotuzumab, lenalidomide, and dexamethasone; HCT: hematopoietic cell transplantation; IRd: ixazomib, lenalidomide, and dexamethasone; IsaKd: isatuximab, carfilzomib, and dexamethasone; IsaPd: isatuximab, pomalidomide, and dexamethasone; KPd: carfilzomib, pomalidomide, and dexamethasone; KRd: carfilzomib, lenalidomide, and dexamethasone; MM: multiple myeloma; SVd: selinexor, bortezomib, and dexamethasone; VCd: bortezomib, cyclophosphamide, and dexamethasone; VPd: bortezomib, pomalidomide, and dexamethasone.
* We use the following cutoffs to define refractory and not refractory MM to guide therapy:Do you want to add Medilib to your home screen?